Dr. Kearns is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2180 Pfingsten Rd
Ste 3000
Glenview, IL 60026Phone+1 847-503-3000Fax+1 847-503-3500
Summary
- Dr. James Kearns is an urologist in Charlotte, NC and is affiliated with Atrium Health's Carolinas Medical Center. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 7 years. He specializes in minimally invasive surgery and surgical oncology and is experienced in prostate cancer and urology.
Education & Training
University of Washington School of MedicineFellowship, Minimally Invasive Urologic Surgery, 2016 - 2018
University of ChicagoResidency, Urology, 2012 - 2016
University of Illinois College of Medicine at ChicagoResidency, Surgery, 2010 - 2012
Columbia University Vagelos College of Physicians and SurgeonsClass of 2010
Clemson UniversityBS, Chemical Engineering, Summa Cum Laude, 2006
Certifications & Licensure
IL State Medical License 2014 - 2026
NC State Medical License 2018 - 2025
SC State Medical License 2020 - 2025
WA State Medical License 2016 - 2019- American Board of Urology Urology
Awards, Honors, & Recognition
- Samuel B. Earle Award 2006
- Faculty Scholarship Award Clemson University, 2006
- Tau Beta Pi 2004
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsIs Active Surveillance Too Active?James T Kearns, Brian T Helfand
Current Urology Reports. 2023-10-01 - 4 citationsSystematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort.Abrar Mian, Jun Wei, Zhuqing Shi, Andrew S Rifkin, S Lilly Zheng
BJUI Compass. 2023-03-01 - Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer.Jason Zhu, Chad Livasy, Erin E Donahue, James T Symanowski, Claud M Grigg
Translational Andrology and Urology. 2023-02-28
Journal Articles
- Reply to Runqiang Yuan's Letter to the Editor Re: James T. Kearns, Anna V. Faino, Lisa F. Newcomb, Et Al. Role of Surveillance Biopsy with No Cancer as a Prognostic Ma...James Kearns, MD, European Urology
- Urodynamic studies in spinal cord tetheringKearns JT, Esposito D, Dooley B, Frim D, Gundeti MS, Childs Nervs Syst, 1/1/2013
- Outcomes of infants undergoing robotic-assisted laparoscopic pyeloplasty compared to open repairDangle PP, Kearns JT, Anderson B, Gundeti MS, J Urol, 1/1/2013
Abstracts/Posters
- Genetic correction of PSA can reduce the number of men diagnosed with potentially insignificant prostate cancer: Results from a surgical and active surveillance cohort.Kearns JT et al, North Central Section, AUA, 1/1/2014
- Distinguishing indolent from aggressive prostate cancer in active surveillance using partial wave spectroscopy to measure nanocytological field carcinogenesis.Kearns JT et al, North Central Section, AUA, 1/1/2014
- Findings of ASAP/PIN are associated with disease progression in active surveillance.Kearns JT et al, AUA Annual Conference, 1/1/2014
- Join now to see all
Press Mentions
Diagnosing Prostate Cancer: Significant Advancements Being MadeOctober 19th, 2021- James Kearns, MD, a Urologist with Levine Cancer Institute – MoreheadSeptember 22nd, 2020
USPSTF Prostate Screening Guidance Had ImpactMay 22nd, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
